Evidence map›Paper›PMID 26387713›Full record

ArticleCurrent biology : CB2015

Transcriptional Control of Synaptic Remodeling through Regulated Expression of an Immunoglobulin Superfamily Protein.

Siwei He, Alison Philbrook, Rebecca McWhirter, Christopher V Gabel, Daniel G Taub, Maximilian H Carter, Isabella M Hanna, Michael M Francis, David M Miller

Abstract read
In one paragraph

Article in Current biology : CB, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Unconventional Myosins fromBiomolecules · 2022
    Review
  8. Article
  9. Article
  10. eLife · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Synaptic remodeling, lessons fromJournal of neurogenetics
    Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Siwei HeNeuroscience Graduate Program, Vanderbilt International Scholar Program, Vanderbilt University, 465 21(st) Avenue South, Nashville, TN 37240-7935, USA.
Alison PhilbrookDepartment of Neurobiology, University of Massachusetts Medical School, 364 Plantation Street, Worcester, MA 01605, USA.
Rebecca McWhirterDepartment of Cell and Developmental Biology, Vanderbilt University, 465 21(st) Avenue South, Nashville, TN 37240-7935, USA.
Christopher V GabelDepartment of Physiology and Biophysics, Boston University Medical Campus, 700 Albany Street, Boston, MA 02118, USA.
Daniel G TaubDepartment of Physiology and Biophysics, Boston University Medical Campus, 700 Albany Street, Boston, MA 02118, USA.
Maximilian H CarterDepartment of Cell and Developmental Biology, Vanderbilt University, 465 21(st) Avenue South, Nashville, TN 37240-7935, USA.
Isabella M HannaDepartment of Cell and Developmental Biology, Vanderbilt University, 465 21(st) Avenue South, Nashville, TN 37240-7935, USA.
Michael M FrancisDepartment of Neurobiology, University of Massachusetts Medical School, 364 Plantation Street, Worcester, MA 01605, USA. Electronic address: michael.francis@umassmed.edu.
David M MillerNeuroscience Graduate Program, Vanderbilt International Scholar Program, Vanderbilt University, 465 21(st) Avenue South, Nashville, TN 37240-7935, USA; Department of Cell and Developmental Biology, Vanderbilt University, 465 21(st) Avenue South, Nashville, TN 37240-7935, USA. Electronic address: david.miller@vanderbilt.edu.

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Kevin L Schey · 1989 to 2026
$19.6M
VANTAGE:Consolidation to create the Vanderbilt Technologies for Advanced GenomicsG20RR030956 · NCRR · VANDERBILT UNIVERSITY · PI PIETENPOL, JENNIFER A · 2010 to 2010
$8.7M
Molecular Analysis of Neural Circuit Excitation and InhibitionR01NS064263 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FRANCIS, MICHAEL M · 2009 to 2025
$5.5M
Molecular Genetics of Synaptic PlasticityR01NS106951 · NINDS · VANDERBILT UNIVERSITY · PI BIANCHI, LAURA, MILLER, DAVID M · 2018 to 2022
$2.2M
Molecular Determination of in vivo Cellular Calcium Signaling During Nerve DamageR01NS077929 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GABEL, CHRISTOPHER V · 2013 to 2017
$1.8M
Molelcular determinants of synaptic plasticityR01NS081259 · NINDS · VANDERBILT UNIVERSITY · PI BIANCHI, LAURA, MILLER, DAVID M · 2013 to 2016
$1.5M
Molecular regulation of nicotinic acetylcholine receptorsF31DA038399 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI PHILBROOK, ALISON · 2015 to 2017
$91k
NCI NIH HHS P30 CA068485NCI NIH HHS P30 CA68485NCRR NIH HHS G20 RR030956NEI NIH HHS P30 EY008126NEI NIH HHS P30 EY08126NIDA NIH HHS F31 DA038399NIDA NIH HHS F31DA038399NIDDK NIH HHS DK058404NIDDK NIH HHS P30 DK058404NINDS NIH HHS R01 NS064263NINDS NIH HHS R01NS064263NINDS NIH HHS R01 NS077929NINDS NIH HHS R01NS077929NINDS NIH HHS R01 NS081259NINDS NIH HHS R01NS081259NINDS NIH HHS R01 NS106951
6 · The paper itself

Abstract

Neural circuits are actively remodeled during brain development, but the molecular mechanisms that trigger circuit refinement are poorly understood. Here, we describe a transcriptional program in C. elegans that regulates expression of an Ig domain protein, OIG-1, to control the timing of synaptic remodeling. DD GABAergic neurons reverse polarity during larval development by exchanging the locations of pre- and postsynaptic components. In newly born larvae, DDs receive cholinergic inputs in the dorsal nerve cord. These inputs are switched to the ventral side by the end of the first larval (L1) stage. VD class GABAergic neurons are generated in the late L1 and are postsynaptic to cholinergic neurons in the dorsal nerve cord but do not remodel. We investigated remodeling of the postsynaptic apparatus in DD and VD neurons using targeted expression of the acetylcholine receptor (AChR) subunit, ACR-12::GFP. We determined that OIG-1 antagonizes the relocation of ACR-12 from the dorsal side in L1 DD neurons. During the L1/L2 transition, OIG-1 is downregulated in DD neurons by the transcription factor IRX-1/Iroquois, allowing the repositioning of synaptic inputs to the ventral side. In VD class neurons, which normally do not remodel, the transcription factor UNC-55/COUP-TF turns off IRX-1, thus maintaining high levels of OIG-1 to block the removal of dorsally located ACR-12 receptors. OIG-1 is secreted from GABA neurons, but its anti-plasticity function is cell autonomous and may not require secretion. Our study provides a novel mechanism by which synaptic remodeling is set in motion through regulated expression of an Ig domain protein.

Indexed as

AcetylcholineAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsGABAergic NeuronsGene Expression RegulationImmunoglobulinsMotor NeuronsNerve Tissue ProteinsReceptors, CholinergicSynapsesTranscription FactorsAcetylcholineCaenorhabditis elegans ProteinsImmunoglobulinsNerve Tissue ProteinsOIG-1 protein, C elegansReceptors, CholinergicTranscription Factors

Identifiers

PMID26387713
PMCPMC4596794

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.